Citation Impact
Citing Papers
Denosumab Compared With Zoledronic Acid for the Treatment of Bone Metastases in Patients With Advanced Breast Cancer: A Randomized, Double-Blind Study
2010 Standout
Treatment With the Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate: Toxicity, Efficacy, and Survival
2008
Sulfur [ 18 F]Fluoride Exchange Click Chemistry Enabled Ultrafast Late-Stage Radiosynthesis
2021 StandoutNobel
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group
2009 Standout
Tumor response and clinical benefit in neuroendocrine tumors after 7.4 GBq (90)Y-DOTATOC.
2002
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Sleep and mental disorders: A meta-analysis of polysomnographic research.
2016
Clinical Practice Guideline for Diagnostic Testing for Adult Obstructive Sleep Apnea: An American Academy of Sleep Medicine Clinical Practice Guideline
2017 Standout
EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision
2010 Standout
Octreotide Versus Octreotide Plus Interferon-Alpha in Endocrine Gastroenteropancreatic Tumors: A Randomized Trial
2005
99mTc-EDDA/HYNIC-TOC: a new 99mTc-labelled radiopharmaceutical for imaging somatostatin receptor-positive tumours: first clinical results and intra-patient comparison with 111In-labelled octreotide derivatives
2000
Nasopharyngeal carcinoma
2005 Standout
Follicular thyroid carcinoma
2002
Ga-66 labeled somatostatin analogue DOTA-DPhe 1 -Tyr 3 -octreotide as a potential agent for positron emission tomography imaging and receptor mediated internal radiotherapy of somatostatin receptor positive tumors
2002
NeuPSIG guidelines on neuropathic pain assessment
2010 Standout
Optimising conditions for radiolabelling of DOTA-peptides with 90Y, 111In and 177Lu at high specific activities
2003
Prevalence and Patterns of Bone Metastases Detected with Positron Emission Tomography Using F-18 FDG
2003
Papillary microcarcinoma of the thyroid—Prognostic significance of lymph node metastasis and multifocality
2003 Standout
Chronic complications of spinal cord injury
2015
114mIn, a candidate for radionuclide therapy: low-energy cyclotron production and labeling of DTPA-D-Phe-octreotide
2000
Clinical radionuclide therapy dosimetry: the quest for the “Holy Gray”
2007
Insomnia as a predictor of mental disorders: A systematic review and meta-analysis
2018
Sleep staging and respiratory events in refractory epilepsy patients: Is there a first night effect?
2008
Progress report on new antiepileptic drugs: a summary of the Seventh Eilat Conference (EILAT VII)
2004
Levetiracetam in spinal cord injury pain: a randomized controlled trial
2009
Skeletal PET with18F-Fluoride: Applying New Technology to an Old Tracer
2007
Glioblastoma and Other Malignant Gliomas
2013 Standout
Head and Neck Squamous Cell Carcinoma: Update on Epidemiology, Diagnosis, and Treatment
2016 Standout
Pharmacology and treatment of neuropathic pains
2009
A new definition of neuropathic pain
2011 Standout
Utility of positron emission tomography for the detection of disease in residual neck nodes after (chemo)radiotherapy in head and neck cancer
2004
Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET
2005
Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival
2011
Central Sensitization and CaVα2δ Ligands in Chronic Pain Syndromes: Pathologic Processes and Pharmacologic Effect
2010
Neuroendocrine tumor targeting: Study of novel gallium‐labeled somatostatin radiopeptides in a rat pancreatic tumor model
2002
Bone mineral density and bone fracture in male patients receiving long-term suppressive levothyroxine treatment for differentiated thyroid carcinoma
2010
Psychedelics
2016 Standout
Cognitive impairment in multiple sclerosis
2008 Standout
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
2011 Standout
Mechanisms of Actions of Inhaled Anesthetics
2003 Standout
Development of an in vitro model for assessing the in vivo stability of lanthanide chelates
2001
Ligand liposomes and boron neutron capture therapy
2003
Biokinetics and imaging with the somatostatin receptor PET radioligand 68Ga-DOTATOC: preliminary data
2001
Life’s Essential 8: Updating and Enhancing the American Heart Association’s Construct of Cardiovascular Health: A Presidential Advisory From the American Heart Association
2022 Standout
Checking consistency in mixed treatment comparison meta‐analysis
2010 Standout
Neuropsychological Impairment in Systemic Lupus Erythematosus: A Comparison with Multiple Sclerosis
2008
Pharmacologic management of neuropathic pain: Evidence-based recommendations
2007 Standout
Clinical applications of newer radionuclide therapies
2006
Tramadol in Neuropathic Pain After Spinal Cord Injury
2009
Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation
2005
Biocatalytic Michael‐Type Additions of Acetaldehyde to Nitroolefins with the Proline‐Based Enzyme 4‐Oxalocrotonate Tautomerase Yielding Enantioenriched γ‐Nitroaldehydes
2013
5HT2A Receptor Binding is Increased in Borderline Personality Disorder
2007
Recent advances in radiological and radionuclide imaging and therapy of neuroendocrine tumours
2004
Neuropathic pain: diagnosis, pathophysiological mechanisms, and treatment
2010 Standout
Comparative Dosimetry of Copper-64 and Yttrium-90-Labeled Somatostatin Analogs in a Tumor-Bearing Rat Model
2000
Design and fabrication of magnetic nanoparticles for targeted drug delivery and imaging
2009 Standout
Spinal Cord Compression in Patients With Advanced Metastatic Cancer
2008
Pathophysiology of the catastrophic antiphospholipid syndrome (CAPS)
2000
The nature and course of sensory changes following spinal cord injury: predictive properties and implications on the mechanism of central pain
2011
Neuroimaging in Traumatic Spinal Cord Injury: An Evidence-based Review for Clinical Practice and Research
2007
Placebo Response Changes Depending on the Neuropathic Pain Syndrome: Results of a Systematic Review and Meta-Analysis
2012
Tumour uptake of the radiolabelled somatostatin analogue [DOTA 0 ,TYR 3 ]octreotide is dependent on the peptide amount
1999
Mild Traumatic Brain Injury in U.S. Soldiers Returning from Iraq
2008 Standout
Pitfalls in the diagnosis of brain tumours
2006
Matching chelators to radiometals for radiopharmaceuticals
2013 Standout
Bench to Bedside: Evidence for Brain Injury after Concussion—Looking beyond the Computed Tomography Scan
2006
Classic Selective Sweeps Revealed by Massive Sequencing in Cattle
2014 Standout
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis
2007
Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial
2007 Standout
Safety and efficacy of pregabalin in patients with central post-stroke pain
2011
Traumatic spinal cord injury
2017 Standout
Pain after Spinal Cord Injury: A Review of Classification, Treatment Approaches, and Treatment Assessment
2009
Somatostatin Analog Therapy in Treatment of Gastrointestinal Disorders and Tumors
2003
Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis
2015 Standout
Radiolabelling DOTA-peptides with 68Ga
2005
The evidence for pharmacological treatment of neuropathic pain
2010
Role of nuclear medicine in the treatment of malignant gliomas: the locoregional radioimmunotherapy approach
2000
Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach
2014 Standout
Pregabalin in patients with central neuropathic pain: A randomized, double-blind, placebo-controlled trial of a flexible-dose regimen
2007
Relationship Between Pain Relief and Improvements in Patient Function/Quality of Life in Patients With Painful Diabetic Peripheral Neuropathy or Postherpetic Neuralgia Treated With Pregabalin
2013
Engineered Nanoparticles for Drug Delivery in Cancer Therapy
2014 Standout
Targeted alpha-radionuclide therapy of functionally critically located gliomas with 213Bi-DOTA-[Thi8,Met(O2)11]-substance P: a pilot trial
2010
A comprehensive review in current developments of benzothiazole-based molecules in medicinal chemistry
2014 Standout
Relative Quantification of Indium-111 Pentetreotide and Gallium-68 DOTATOC Uptake in the Thyroid Gland and Association with Thyroid Pathologies
2009
Revised American Thyroid Association Guidelines for the Management of Medullary Thyroid Carcinoma
2015 Standout
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Taskforce
2006 Standout
Medullary Thyroid Cancer: Management Guidelines of the American Thyroid Association
2009 Standout
A genome‐wide scan for signatures of recent selection in Holstein cattle
2010
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
2000
111In-labeled 1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid-lys(8)-vasotocin: a new powerful radioligand for oxytocin receptor-expressing tumors.
2001
Radiotherapy and dosimetry of 64Cu-TETA-Tyr3-octreotate in a somatostatin receptor-positive, tumor-bearing rat model.
1999
Pharmacological interventions for somatoform disorders in adults
2014 Standout
Pregabalin for acute and chronic pain in adults
2009
Neuropathic Pain
2009
The Clinical Significance of Subclinical Thyroid Dysfunction
2007
CDC Guideline for Prescribing Opioids for Chronic Pain—United States, 2016
2016 Standout
Physiological and Molecular Basis of Thyroid Hormone Action
2001 Standout
Neuropathic Pain: From Mechanisms to Treatment
2020 Standout
Comparison of 111In-DOTA-Tyr3-octreotide and 111In-DTPA-octreotide in the same patients: biodistribution, kinetics, organ and tumor uptake.
1999
Neuropathic pain prevalence following spinal cord injury: A systematic review and meta‐analysis
2016
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
Glycosylated DOTA−α-Melanocyte-Stimulating Hormone Analogues for Melanoma Targeting: Influence of the Site of Glycosylation on in Vivo Biodistribution
2009
Radiolabeled Somatostatin Analog [177Lu-DOTA0,Tyr3]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
2005
Pharmacological Management of Chronic Neuropathic Pain: Revised Consensus Statement from the Canadian Pain Society
2014
Guidelines for Adult Stroke Rehabilitation and Recovery
2016 Standout
213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
2006
18F-Labeling of Arenes and Heteroarenes for Applications in Positron Emission Tomography
2016
Trends in the Incidence, Prevalence, and Survival Outcomes in Patients With Neuroendocrine Tumors in the United States
2017 Standout
Annexins: From Structure to Function
2002 Standout
Chemomimetic Biocatalysis: Exploiting the Synthetic Potential of Cofactor-Dependent Enzymes To Create New Catalysts
2015 StandoutNobel
Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
2005 Standout
Diabetic Neuropathy: A Position Statement by the American Diabetes Association
2016 Standout
Guidelines for the management of thyroid cancer
2014 Standout
The Effect of Thyroid Hormone on Skeletal Integrity
1999
Isoflurane Action in the Spinal Cord Blunts Electroencephalographic and Thalamic–Reticular Formation Responses to Noxious Stimulation in Goats
2000
1,4,7-Triazacyclononane-1-succinic acid-4,7-diacetic acid (NODASA): a new bifunctional chelator for radio gallium-labelling of biomolecules
1998
Systematic reviews: CRD's guidance for undertaking reviews in health care
2010 Standout
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
2003
Evaluation of the Pharmacokinetic Effects of Various Linking Group Using the 111In-DOTA-X-BBN(7−14)NH2 Structural Paradigm in a Prostate Cancer Model
2008
Works of Andreas Otte being referenced
DOTATOC: A powerful new tool for receptor-mediated radionuclide therapy
1997
Gabapentin versus Lamotrigine Monotherapy: A Double‐blind Comparison in Newly Diagnosed Epilepsy
2002
Radiolabeled immunotherapy in non-Hodgkin's lymphoma treatment: the next step
2009
Estimates of regional cerebral blood flow and 5-HT2A receptor density in impulsive, aggressive dogs with 99mTc-ECD and 123I-5-I-R91150
2003
Neuro-Behçet's Syndrome in a Patient not Fulfilling Criteria for Behçet's Disease: Clinical Features and Value of Brain Imaging
2000
The neurobiology, investigation, and treatment of chronic insomnia
2015
Nuclear medicine imaging for the assessment of primary and recurrent head and neck carcinoma using routinely available tracers
2003
Combined FDG and [F-18]fluoride whole-body PET: a feasible two-in-one approach to cancer imaging?
1998
Renal Toxicity after Radionuclide Therapy
2004
Subjective Sleep Disturbance in Patients with Partial Epilepsy: A Questionnaire‐based Study on Prevalence and Impact on Quality of Life
2004
Brain glucose utilization in systemic lupus erythematosus with neuropsychiatric symptoms: A controlled positron emission tomography study
1997
End-stage renal disease after treatment with 90 Y-DOTATOC
2001
Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.
1999
Neuropsychiatric systemic lupus erythematosus before and after immunosuppressive treatment: a FDG PET study
1998
Imaging of mild traumatic brain injury using 57Co and 99mTc HMPAO SPECT as compared to other diagnostic procedures.
2003
PET and SPECT in Neurology
2014
[Yttrium 90 DOTATOC: a new somatostatin analog for cancer therapy of neuroendocrine tumors].
1999
DOTATOC: a powerful new tool for receptor-mediated radionuclide therapy
1997
Bone mineral density in patients receiving suppressive doses of thyroxine for differentiated thyroid carcinoma
1996
Yttrium-90 DOTATOC: first clinical results
1999
Influence of spinal cord injury on cerebral sensorimotor systems: a PET study.
1997
Pregabalin in central neuropathic pain associated with spinal cord injury
2006